{"database": "lobbying", "table": "lobbying_activities", "rows": [[1873083, "f9c78500-5835-4c11-a529-84c44ef8a147", "Q3", "CAPITOL LEGISLATIVE STRATEGIES LLC", 400432093, "EMERGENT BIOSOLUTIONS INC.", 2016, "third_quarter", "HOM", "Federal budget and appropriations provisions related to development, acquisition and stockpiling of biodefense vaccines.\nS.1915--First Responder Anthrax Preparedness Act\nWMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.\nImplementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-05T09:31:36.460000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1873083"], "units": {}, "query_ms": 15.241021988913417, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}